{"retracted":false,"update":{"timestamp":1457481600000,"doi":"10.1007/s10549-016-3703-5","type":"correction"},"doi":"10.1007/s10549-012-2080-y","journal":"Breast Cancer Research and Treatment","publisher":"Springer Nature","title":"Erratum to: Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients"}
